Impact of COVID-19 vaccine doses and viral waves on inflammatory and immunological responses to COVID-19 infections in India
Authors:
- Kamal Kant SharmaKSKamal Kant Sharma
- Pradeep D’costaPDPradeep D’costa
- Yatin DholakiaYDYatin Dholakia
Preprint
Abstract
Background: Investigation of the effect of SARS-CoV-2 variants and COVID-19 vaccination on inflammatory and immune response to SARS-CoV-2 infection is limited in South Asia. Objectives: We aimed to examine the impact of COVID-19 vaccination and waves of COVID- 19 on inflammatory and immunological biomarkers among COVID-19 patients in India. Methods: This cross-sectional analysis used baseline data from a randomized controlled trial of vitamin D and zinc during COVID-19 infection in India (N=181). Blood samples and data regarding vaccination doses were collected. The second (Delta) or third (Omicron) wave was determined by date of enrolment. Mixed effects linear regression with robust standard errors was used to examine associations between COVID-19 vaccination dose or wave at enrolment and C-Reactive Protein (CRP), ferritin, lactate dehydrogenase (LDH), D-dimer, interleukin-6 (IL-6), angiopoietin-2 (Ang-2), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), immunoglobulin G (IgG) and immunoglobulin M (IgM). Results: Compared to no vaccination, full vaccination was associated with lower LDH ( P< 0.001), D-dimer ( P= 0.521) and Ang-2 ( P= 0.046), and higher IgG levels ( P< 0.001). Partial vaccination was associated with lower IL-6 ( P= 0.040) and higher IgG ( P< 0.001). Enrolment during the third wave was associated with lower IL-6 ( P< 0.001), CRP ( P= 0.056), IgM ( P= 0.013), and IgG ( P< 0.001), but higher D-dimer levels ( P< 0.001). Conclusions: COVID-19 vaccination status and SARS-CoV-2 variant influence the inflammatory and immunologic response during SARS-CoV-2 infection, contributing to the severity of clinical presentation.Keywords
This publication has 25 references indexed in Scilit:
- Impact of COVID‐19 vaccination on transmission risk of breakthrough infections: Lessons from adapted N95 mask sampling for emerging variants and interventionsJournal of Medical Virology, 2022
- Laboratory markers of severity across three COVID-19 outbreaks in Australia: has Omicron and vaccinations changed disease presentation?Internal and Emergency Medicine, 2022
- Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)IJID Regions, 2022
- Clinical presentation, pregnancy complications, and outcomes of pregnant women with COVID ‐19 during the Omicron‐dominant third wave in Mumbai, IndiaInternational Journal of Gynecology & Obstetrics, 2022
- Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID StudyThe Lancet, 2022
- T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variantCellular & Molecular Immunology, 2022
- Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymoreJournal of Thrombosis and Thrombolysis, 2021
- The most important biomarker associated with coagulation and inflammation among COVID-19 patientsMolecular and Cellular Biochemistry, 2021
- Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseasesClinical Rheumatology, 2020
- Correlates of D-dimer in older personsAging Clinical and Experimental Research, 2010